Start-up to study peptides that modulate gene expression
Drug Discovery World
AUGUST 31, 2023
Other potential cancer indications with ongoing in vitro work include breast and ovarian cancer. HBCI’s CEO, Dr Bomi Framroze said: “HBCI is at the forefront of research in using peptides to modulate gene expression. Our first therapeutic target is resistant castration-resistant prostate cancer (CRPC).
Let's personalize your content